Rezultati - Natalia Muñoz‐Durango

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension

    Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension od Natalia Muñoz‐Durango, Cristóbal Fuentes, Andrés Castillo, Luis M González-Gómez, Andrea Vecchiola, Carlos Fardella, Alexis M. Kalergis

    Izdano 2016
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone

    Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone od Natalia Muñoz‐Durango, Andrea Vecchiola, Luis M González-Gómez, Felipe Simón, Claudia A. Riedel, Carlos Fardella, Alexis M. Kalergis

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Interleukin‐10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by <i>Streptococcus pneumoniae</i>

    Interleukin‐10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by <i>Streptococcus pneumoniae</i> od Hernán F. Peñaloza, Pamela A. Nieto, Natalia Muñoz‐Durango, Francisco J. Salazar‐Echegarai, Javiera Torres, María J. Parga, Manuel Álvarez-Lobos, Claudia A. Riedel, Alexis M. Kalergis, Susan M. Bueno

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

    Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial od Katia Abarca, Emma Rey-Jurado, Natalia Muñoz‐Durango, Yaneisi Vázquez, Jorge A. Soto, Nicolás M. S. Gálvez, Javier Valdés-Ferrada, Carolina Iturriaga, Marcela Urzúa, Arturo Borzutzky, Jaime Cerda, Luis Villarroel, Victoria Madrid, Pablo A. González, José Vicente González-Aramúndiz, Susan M. Bueno, Alexis M. Kalergis

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: